A Case of Plurihormonal Pituitary Giant Macroadenoma

Hatice Özişik, Banu SARER YÜREKLİ, Y. Ertan, C. Eraslan, E. Özgiray, F. Saygili
{"title":"A Case of Plurihormonal Pituitary Giant Macroadenoma","authors":"Hatice Özişik, Banu SARER YÜREKLİ, Y. Ertan, C. Eraslan, E. Özgiray, F. Saygili","doi":"10.25179/tjem.2020-78997","DOIUrl":null,"url":null,"abstract":"Introduction Pituitary adenomas producing more than one pituitary hormone are defined as plurihormonal pituitary adenomas (PPA) according to the 2017 World Health Organization (WHO) classification of pituitary tumors (1). While the majority of functioning pituitary adenomas produce a single hormone, an imWe would like to draw the attention of the readers to Pit-1 positive giant macroadenomas in this work. A 62-year-old male patient was admitted to the hospital due to his vision loss and blurred vision in the left eye. His pituitary magnetic resonance imaging revealed the presence of a diffuse and homogeneous mass lesion originating from the pituitary gland having grade 4 invasion into the bilateral cavernous sinus and eroding the base of the sella. He consulted our department before his operation in 2016. Laboratory examination revealed that pituitary hormone levels were within normal ranges while the testosterone level [total testosterone 0.27 ng/mL (2.8-8)] was low. Pathological findings revealed a pituitary adenoma that displayed focal immunoreactivity to thyrotrophin, growth hormone, and prolactin. While the main prevalence and the basic mechanism of plurihormonal pituitary adenomas are not clear, one of the hypotheses is based on the role of divergent transcription factors such as Pit-1. According to this condition, we should perform a complete biochemical and histologic evaluation in patients with pituitary adenomas.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"75 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Turkish Journal of Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25179/tjem.2020-78997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Pituitary adenomas producing more than one pituitary hormone are defined as plurihormonal pituitary adenomas (PPA) according to the 2017 World Health Organization (WHO) classification of pituitary tumors (1). While the majority of functioning pituitary adenomas produce a single hormone, an imWe would like to draw the attention of the readers to Pit-1 positive giant macroadenomas in this work. A 62-year-old male patient was admitted to the hospital due to his vision loss and blurred vision in the left eye. His pituitary magnetic resonance imaging revealed the presence of a diffuse and homogeneous mass lesion originating from the pituitary gland having grade 4 invasion into the bilateral cavernous sinus and eroding the base of the sella. He consulted our department before his operation in 2016. Laboratory examination revealed that pituitary hormone levels were within normal ranges while the testosterone level [total testosterone 0.27 ng/mL (2.8-8)] was low. Pathological findings revealed a pituitary adenoma that displayed focal immunoreactivity to thyrotrophin, growth hormone, and prolactin. While the main prevalence and the basic mechanism of plurihormonal pituitary adenomas are not clear, one of the hypotheses is based on the role of divergent transcription factors such as Pit-1. According to this condition, we should perform a complete biochemical and histologic evaluation in patients with pituitary adenomas.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
垂体多激素巨大腺瘤1例
根据2017年世界卫生组织(WHO)垂体肿瘤分类(1),产生一种以上垂体激素的垂体腺瘤被定义为多激素垂体腺瘤(PPA)。虽然大多数功能性垂体腺瘤只产生一种激素,但我们希望在本工作中引起读者对Pit-1阳性巨大腺瘤的注意。一名62岁男性患者因视力下降和左眼视力模糊而入院。他的垂体磁共振成像显示存在一个起源于垂体的弥漫性均匀肿块病变,侵犯双侧海绵窦并侵蚀鞍底,程度为4级。他在2016年手术前咨询了我们的科室。实验室检查垂体激素水平正常,睾酮水平低[总睾酮0.27 ng/mL(2.8 ~ 8)]。病理结果显示垂体腺瘤对促甲状腺素、生长激素和催乳素表现局灶性免疫反应。虽然多激素垂体腺瘤的主要患病率和基本机制尚不清楚,但其中一种假设是基于诸如Pit-1之类的分化转录因子的作用。根据这种情况,我们应该对垂体腺瘤患者进行完整的生化和组织学评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evidence-Based Medicine or Patient-Directed Treatment? Comparison of Screening Strategies for Bone Mineral Density Measurement Overlapping Between Thymus Neuroendocrine Carcinoma as an Ectopic Cushing Syndrome and Exogenous Cushing’s Syndrome: A Case Report Postpartum Metabolic Outcomes and Related Factors in Women with Gestational Diabetes Mellitus History A Case of Plurihormonal Pituitary Giant Macroadenoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1